Dual Targeting of GyrB and ParE by a Novel Aminobenzimidazole Class of Antibacterial Compounds

A structure-guided drug design approach was used to optimize a novel series of aminobenzimidazoles that inhibit the essential ATPase activities of bacterial DNA gyrase and topoisomerase IV and that show potent activities against a variety of bacterial pathogens. Two such compounds, VRT-125853 and VR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grossman, Trudy H., Bartels, Douglas J., Mullin, Steve, Gross, Christian H., Parsons, Jonathan D., Liao, Yusheng, Grillot, Anne-Laure, Stamos, Dean, Olson, Eric R., Charifson, Paul S., Mani, Nagraj
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Mechanisms of Action: Physiological Effects
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797739/
https://ncbi.nlm.nih.gov/pubmed/17116675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00596-06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados